InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.17
(
-0.25%
)
US TECH 100
19,288.80
(
-0.62%
)
Dow Jones
39,134.76
(
0.77%
)
Brent Oil
84.89
(
-0.14%
)
Bitcoin
64,574.78
(
-0.38%
)
Post# of 252279
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jaybe

Send PM Follow Ignore
Followers 5
Posts 277
Boards Moderated 0
Alias Born 05/29/2011

jaybe

Re: biomaven0 post# 162583

Sunday, 06/16/2013 11:13:26 AM

Sunday, June 16, 2013 11:13:26 AM

Post# of 252279
I think the battle for best 2nd gen ALK inhibitors will be decided on durability of response, PFS and OS. I know '113 and LDK also have activity in brain mets, but moving the needle on PFS past 9.7 mos (Criz) will be the true test for a next generation ALK inhibitor. This means waiting another 12-18 months for '113 and Chugai/Roche to have such data to compare against LDK.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up